miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Area of Science:

• Oncology
• Molecular Biology
• Biomarker Discovery

Background:

• Current prostate cancer (PCa) biomarkers are insufficient for effective clinical management.
• MicroRNAs (miRNAs) show promise as diagnostic and prognostic biomarkers for PCa.
• Accurate detection of miRNAs in clinical prostate tissues is essential but challenging due to factors like tumor heterogeneity.

Purpose of the Study:

• To describe a simplified and optimized workflow for miRNA analysis in archived formalin-fixed paraffin-embedded (FFPE) and fresh-frozen prostate cancer specimens.
• To enhance the accuracy and reliability of miRNA detection for improved PCa biomarker development.

Main Methods:

• Optimization of miRNA extraction from FFPE and frozen prostate tissues.
• Development of Taqman-probe based quantitative real-time PCR (RT-PCR) for miRNA expression analysis.
• Optimization of in situ hybridization (ISH) using locked nucleic acid (LNA)-based probes for miRNA detection in prostate tissues.

Main Results:

• An optimized workflow combining RT-PCR and ISH for miRNA analysis in prostate cancer tissues was established.
• Improved methodologies for miRNA extraction and expression analysis were detailed.
• An optimized LNA-based ISH protocol suitable for tissue slides and tissue microarrays (TMA) was developed.

Conclusions:

• The presented workflow offers a simplified and effective approach for miRNA analysis in prostate cancer clinical specimens.
• This optimized methodology can facilitate the development of miRNAs as reliable biomarkers for prostate cancer diagnosis and prognosis.
• The protocol is adaptable for various prostate cancer tissue formats, including FFPE, frozen tissues, slides, and TMAs.